AES CORP. DL-01/ US00130H1059 /
20/09/2024 17:31:54 | Chg. -0.9000 | Volume | Bid21:59:59 | Ask21:59:59 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
16.8500EUR | -5.07% | 105 Turnover: 1,769.2500 |
16.8300Bid Size: 670 | 17.0060Ask Size: 670 | 12.04 bill.EUR | - | - |
Newsfile Corp
19/09
Perseverance Metals Discovers New Nickel Zone, Yields 1.82% NiEq over 5.1 Meters at Lac Gayot Projec...
Newsfile Corp
17/09
Endurance Announces First 2024 Drill Results At The Reliance Gold Project, BC; Initial Six Holes Exp...
GlobeNewswire
30/08
IO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA® (pembrolizu...
GlobeNewswire
28/08
Orchard Therapeutics Announces Multiple Presentations from across its Late-stage Neurometabolic Port...
Newsfile Corp
26/08
ALX Resources Corp. Completes Prospecting and Sampling Programs at the Cannon Copper Project, Ontari...
GlobeNewswire
22/08
Cognition Therapeutics Publishes EEG Findings from Phase 2 SEQUEL Study of CT1812 in Mild-to-Moderat...
Newsfile Corp
20/08
Appia Confirms Outstanding Desorption Results From Its Ionic Adsorption Clay Targets Maia, Electra, ...
GlobeNewswire
15/08
Great Place To Work® Announces the 2024 Best Workplaces in Latin America Representing 3.8 Million Em...
GlobeNewswire
14/08
Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic...
GlobeNewswire
14/08
Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
12/08
Avalyn Announces Initiation of Phase 1b Clinical Study for AP02, its Novel Inhaled Nintedanib
GlobeNewswire
12/08
Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at...
GlobeNewswire
08/08
Apellis and Sobi Announce Positive Topline Results from Phase 3 VALIANT Study of Pegcetacoplan in C3...
GlobeNewswire
06/08
Paperclip Partners With Flying Cloud Technology, Premier Federal to Create Zero Trust Data Safe Plat...
GlobeNewswire
01/08
Agios Announces Results from Phase 3 ACTIVATE-KidsT Study of Mitapivat in Children with PK Deficienc...